IDH1-mut glioma cells lowered NAD+ levels by silencing the NAD+ salvage enzyme nicotinic acid phosphoribosyltransferase (NAPRT) and are sensitive to the block of NAD+ biosynthesis via nicotinamide phosphoribosyltransferase (NAMPT) inhibition [28]. Here, IDH1 is linked to central nervous system cancer.